| rs1595066 |
chr2 |
212241725 |
0.0000947 |
C |
T |
Monocyte chemoattractant protein-1 |
ERBB4 |
UTR-3 |
pha003071
|
| rs10932374 |
chr2 |
212244403 |
0.0000258 |
G |
A |
Paclitaxel-induced neuropathy |
ERBB4 |
UTR-3 |
23776197
|
| rs10932374 |
chr2 |
212244403 |
0.0000942 |
G |
A |
HDL cholesterol |
ERBB4 |
UTR-3 |
pha003075
|
| rs17744862 |
chr2 |
212244520 |
0.000212 |
A |
G |
Lung function (forced expiratory flow between 25% and 75% of forced vital capacity) |
ERBB4 |
UTR-3 |
24023788
|
| rs3791682 |
chr2 |
212249706 |
0.00086 |
T |
C |
Myopia (pathological) |
ERBB4 |
intron |
21095009
|
| rs3791682 |
chr2 |
212249706 |
0.0000956 |
T |
C |
HDL cholesterol |
ERBB4 |
intron |
pha003074
|
| rs3791682 |
chr2 |
212249706 |
0.0000261 |
T |
C |
HDL cholesterol |
ERBB4 |
intron |
pha003075
|
| rs1595062 |
chr2 |
212251070 |
0.000276 |
A |
G |
Taste perception |
ERBB4 |
intron |
22132133
|
| rs149419131 |
chr2 |
212331808 |
0.0000461 |
C |
G |
Nonsyndromic striae distensae (stretch marks) |
ERBB4 |
intron |
23633020
|
| rs13021324 |
chr2 |
212350245 |
0.000159 |
T |
C |
Epilepsy |
ERBB4 |
intron |
22116939
|
| rs9941626 |
chr2 |
212351667 |
0.000123 |
T |
G |
Epilepsy |
ERBB4 |
intron |
22116939
|
| rs4500888 |
chr2 |
212368188 |
0.0000815 |
G |
T |
Multiple complex diseases |
ERBB4 |
intron |
17554300
|
| rs6435632 |
chr2 |
212378524 |
0.0000282 |
G |
A |
Multiple complex diseases |
ERBB4 |
intron |
17554300
|
| rs7603778 |
chr2 |
212384650 |
0.0000098 |
T |
C |
Urinary metabolites |
ERBB4 |
intron |
21572414
|
| rs7597024 |
chr2 |
212386461 |
0.0000076 |
C |
T |
Urinary metabolites |
ERBB4 |
intron |
21572414
|
| rs11887047 |
chr2 |
212409199 |
0.0000776 |
G |
C |
Placental abruption |
ERBB4 |
intron |
23205182
|
| rs13014132 |
chr2 |
212415917 |
0.000508 |
C |
G |
Multiple complex diseases |
ERBB4 |
intron |
17554300
|
| rs13421680 |
chr2 |
212416029 |
0.000442 |
A |
G |
Alcohol dependence |
ERBB4 |
intron |
21314694
|
| rs11885579 |
chr2 |
212431529 |
0.000938 |
A |
G |
Alcohol dependence |
ERBB4 |
intron |
21314694
|
| rs12694242 |
chr2 |
212438861 |
0.000051 |
T |
C |
HIV-1 control |
ERBB4 |
intron |
20041166
|
| rs1879532 |
chr2 |
212439312 |
0.000000166 |
T |
C,G |
Autism |
ERBB4 |
intron |
22843504
|
| rs4672619 |
chr2 |
212457195 |
0.000363 |
C |
A |
Lung function (forced expiratory volume in 1 second to forced vital capacity ratio) |
ERBB4 |
intron |
24023788
|
| rs1851196 |
chr2 |
212470620 |
0.00000214 |
G |
A |
Schizophrenia |
ERBB4 |
intron |
19571809
|
| rs1851196 |
chr2 |
212470620 |
0.00000511 |
G |
A |
Schizophrenia |
ERBB4 |
intron |
pha002859
|
| rs41382849 |
chr2 |
212471471 |
0.000693 |
G |
A |
Multiple complex diseases |
ERBB4 |
intron |
17554300
|
| rs12616462 |
chr2 |
212490272 |
0.0000365 |
A |
C |
Tuberculosis |
ERBB4 |
intron |
20694014
|
| rs10180037 |
chr2 |
212508067 |
0.00055 |
T |
C |
Taste perception |
ERBB4 |
intron |
22132133
|
| rs6706854 |
chr2 |
212508134 |
0.000257 |
A |
G |
Type 2 diabetes |
ERBB4 |
intron |
17463246
|
| rs17335518 |
chr2 |
212526025 |
0.0000031 |
A |
G |
Urinary metabolites |
ERBB4 |
intron |
21572414
|
| rs10173674 |
chr2 |
212545533 |
0.000856 |
C |
T |
Amyotrophic Lateral Sclerosis |
ERBB4 |
intron |
17362836
|
| rs7588792 |
chr2 |
212626917 |
0.000602 |
A |
C |
Type 2 diabetes |
ERBB4 |
intron |
17463246
|
| rs1371200 |
chr2 |
212691392 |
0.000751 |
G |
T |
Taste perception |
ERBB4 |
intron |
22132133
|
| rs16846917 |
chr2 |
212697542 |
0.0000154 |
G |
T |
Multiple sclerosis (brain glutamate levels) |
ERBB4 |
intron |
20802204
|
| rs6435678 |
chr2 |
212710468 |
0.000601 |
G |
C |
Multiple complex diseases |
ERBB4 |
intron |
17554300
|
| rs6435678 |
chr2 |
212710468 |
0.000306 |
G |
C |
Nicotine smoking |
ERBB4 |
intron |
19268276
|
| rs1159709 |
chr2 |
212715410 |
0.0000117 |
T |
C |
Multiple sclerosis (brain glutamate levels) |
ERBB4 |
intron |
20802204
|
| rs16847102 |
chr2 |
212722988 |
0.000759 |
G |
A |
Multiple complex diseases |
ERBB4 |
intron |
17554300
|
| rs11679499 |
chr2 |
212729377 |
0.00085 |
A |
T |
Acute lung injury |
ERBB4 |
intron |
22295056
|
| rs16847152 |
chr2 |
212736394 |
0.0000792 |
T |
C |
Cognitive impairment induced by topiramate |
ERBB4 |
intron |
22091778
|
| rs13390226 |
chr2 |
212739861 |
0.0000424 |
G |
A |
Multiple complex diseases |
ERBB4 |
intron |
17554300
|
| rs7603039 |
chr2 |
212788895 |
0.0001 |
G |
A |
Normoxic and mild-hypoxic adaptation in populations residing at low and moderate altitudes |
ERBB4 |
intron |
22628534
|
| rs16847207 |
chr2 |
212791249 |
0.000738 |
A |
G |
Height (Pygmy height) |
ERBB4 |
intron |
22570615
|
| rs839533 |
chr2 |
212808107 |
0.000159 |
A |
G |
Oxaliplatin induced mucositis in response to colorectal cancer treatment |
ERBB4 |
intron |
22310351
|
| rs839511 |
chr2 |
212822242 |
0.000469 |
C |
T |
Alzheimer's disease |
ERBB4 |
intron |
17998437
|
| rs839511 |
chr2 |
212822242 |
0.000258 |
C |
T |
Alzheimer's disease |
ERBB4 |
intron |
pha002879
|
| rs10205607 |
chr2 |
212845461 |
0.000849 |
T |
C |
Salmonella-induced pyroptosis |
ERBB4 |
intron |
22837397
|
| rs17415079 |
chr2 |
212856363 |
0.000573 |
T |
C |
Smoking initiation |
ERBB4 |
intron |
24665060
|
| rs4673646 |
chr2 |
212860841 |
0.000708 |
G |
A |
Salmonella-induced pyroptosis |
ERBB4 |
intron |
22837397
|
| rs13020474 |
chr2 |
212866473 |
0.000369 |
C |
T |
Salmonella-induced pyroptosis |
ERBB4 |
intron |
22837397
|
| rs1879637 |
chr2 |
212868624 |
0.000004 |
C |
T |
Personality dimensions |
ERBB4 |
intron |
23903073
|
| rs1521537 |
chr2 |
212885510 |
0.0000657 |
T |
C |
Circulating PCSK9 levels |
ERBB4 |
intron |
22460556
|
| rs2139938 |
chr2 |
212891137 |
0.0000049 |
C |
A |
Urinary metabolites |
ERBB4 |
intron |
21572414
|
| rs1546717 |
chr2 |
212902339 |
0.000026 |
A |
G |
Urinary metabolites |
ERBB4 |
intron |
21572414
|
| rs1464443 |
chr2 |
212914726 |
0.000001 |
C |
A |
Amyotrophic lateral sclerosis (sporadic) |
ERBB4 |
intron |
24529757
|
| rs41422148 |
chr2 |
212967009 |
0.000198 |
T |
C |
Multiple complex diseases |
ERBB4 |
intron |
17554300
|
| rs16847757 |
chr2 |
212994669 |
0.000253 |
T |
C |
Multiple complex diseases |
ERBB4 |
intron |
17554300
|
| rs4673651 |
chr2 |
213004603 |
0.00000608 |
G |
A,T |
Aging |
ERBB4 |
intron |
22445811
|
| rs13035998 |
chr2 |
213029668 |
0.0000231 |
T |
C |
Serum metabolites |
ERBB4 |
intron |
19043545
|
| rs6751662 |
chr2 |
213033118 |
0.0000177 |
T |
C |
Serum metabolites |
ERBB4 |
intron |
19043545
|
| rs1402766 |
chr2 |
213033301 |
0.00000774 |
A |
C |
Rheumatoid arthritis |
ERBB4 |
intron |
19503088
|
| rs12621602 |
chr2 |
213036190 |
0.000000188 |
A |
C |
Fibrinogen |
ERBB4 |
intron |
pha003068
|
| rs939664 |
chr2 |
213038087 |
0.0000785 |
C |
G |
Serum metabolites |
ERBB4 |
intron |
19043545
|
| rs10497963 |
chr2 |
213065329 |
0.0000542 |
C |
T |
Bilirubin levels,in serum |
ERBB4 |
intron |
19389676
|
| rs1402769 |
chr2 |
213081443 |
0.0000446 |
T |
G |
Chronic obstructive pulmonary disease |
ERBB4 |
intron |
19300482
|
| rs1402769 |
chr2 |
213081443 |
0.0000446 |
T |
G |
Response to statin treatment (atorvastatin),change in cholesterol levels |
ERBB4 |
intron |
20031582
|
| rs9288446 |
chr2 |
213082027 |
0.000023 |
G |
C |
Volumetric brain MRI |
ERBB4 |
intron |
17903297
|
| rs9288449 |
chr2 |
213085996 |
0.000144 |
T |
C |
Response to statin treatment (atorvastatin),change in cholesterol levels |
ERBB4 |
intron |
20031582
|
| rs10497966 |
chr2 |
213113079 |
0.000099 |
C |
A |
Psoriasis |
ERBB4 |
intron |
18364390
|
| rs1021916 |
chr2 |
213132822 |
0.000022 |
A |
G |
Renal function-related traits (urea) |
ERBB4 |
intron |
22797727
|
| rs10170838 |
chr2 |
213164466 |
0.000000976 |
C |
T |
Type 1 diabetes nephropathy |
ERBB4 |
intron |
23028342
|
| rs1857795 |
chr2 |
213164907 |
0.00003 |
A |
C |
Prostate cancer |
ERBB4 |
intron |
21743057
|
| rs17346933 |
chr2 |
213165193 |
0.0000577 |
A |
G |
Left ventricular hypertrophy |
ERBB4 |
intron |
pha003052
|
| rs7588550 |
chr2 |
213168768 |
0.0000002 |
G |
A |
Type 1 diabetes nephropathy |
ERBB4 |
intron |
23028342
|
| rs7559911 |
chr2 |
213186351 |
0.000202 |
C |
A |
Response to taxane treatment (placlitaxel) |
ERBB4 |
intron |
23006423
|
| rs10164675 |
chr2 |
213187034 |
0.000871 |
G |
T |
Response to taxane treatment (placlitaxel) |
ERBB4 |
intron |
23006423
|
| rs12993440 |
chr2 |
213188013 |
0.000206 |
A |
G |
Response to taxane treatment (placlitaxel) |
ERBB4 |
intron |
23006423
|
| rs905883 |
chr2 |
213188470 |
0.0002 |
C |
A,G,T |
Breast cancer and prostate cancer |
ERBB4 |
intron |
17903305
|
| rs16775 |
chr2 |
213189297 |
0.0000906 |
G |
A |
Schizophrenia |
ERBB4 |
intron |
24253340
|
| rs4673659 |
chr2 |
213189729 |
0.0000009 |
A |
C |
Asthma (sex interaction) |
ERBB4 |
intron |
24824216
|
| rs6719811 |
chr2 |
213194405 |
0.000827 |
G |
A |
Response to taxane treatment (placlitaxel) |
ERBB4 |
intron |
23006423
|
| rs1394782 |
chr2 |
213200920 |
0.000083 |
G |
A |
Pericardial fat |
ERBB4 |
intron |
22589742
|
| rs1505356 |
chr2 |
213205001 |
0.000087 |
C |
A |
Pericardial fat |
ERBB4 |
intron |
22589742
|
| rs1876048 |
chr2 |
213205849 |
0.000094 |
G |
A |
Pericardial fat |
ERBB4 |
intron |
22589742
|
| rs1995567 |
chr2 |
213206165 |
0.000643 |
T |
C |
Response to statin treatment (atorvastatin),change in cholesterol levels |
ERBB4 |
intron |
20031582
|
| rs2135157 |
chr2 |
213206302 |
0.000094 |
C |
T |
Pericardial fat |
ERBB4 |
intron |
22589742
|
| rs4630710 |
chr2 |
213211617 |
0.000266 |
G |
A |
Response to statin treatment (atorvastatin),change in cholesterol levels |
ERBB4 |
intron |
20031582
|
| rs2888089 |
chr2 |
213219281 |
0.000064 |
C |
A |
Pericardial fat |
ERBB4 |
intron |
22589742
|
| rs1948877 |
chr2 |
213219641 |
0.000509 |
G |
A |
Type 2 diabetes |
ERBB4 |
intron |
17463246
|
| rs11892564 |
chr2 |
213226544 |
0.000808 |
A |
G |
Alzheimer's disease |
ERBB4 |
intron |
24755620
|
| rs1394799 |
chr2 |
213230879 |
0.000742 |
A |
G |
Response to taxane treatment (placlitaxel) |
ERBB4 |
intron |
23006423
|
| rs4511675 |
chr2 |
213233739 |
0.000093 |
G |
T |
Alzheimer's disease (late onset) |
ERBB4 |
intron |
21379329
|
| rs13383860 |
chr2 |
213253930 |
0.00000611 |
T |
C |
Alzheimer's disease (late onset) |
ERBB4 |
intron |
21379329
|
| rs16848495 |
chr2 |
213273682 |
0.000345 |
C |
T |
Type 2 diabetes |
ERBB4 |
intron |
17463246
|
| rs1283310 |
chr2 |
213273891 |
0.00000764 |
A |
G |
Serum dimethylarginine levels (symmetric) |
ERBB4 |
intron |
24159190
|
| rs10197836 |
chr2 |
213274278 |
0.00000776 |
T |
C |
Serum dimethylarginine levels (symmetric) |
ERBB4 |
intron |
24159190
|
| rs4673664 |
chr2 |
213277649 |
0.0000083 |
T |
C |
Serum dimethylarginine levels (symmetric) |
ERBB4 |
intron |
24159190
|
| rs10167244 |
chr2 |
213281310 |
0.00000617 |
A |
G |
Serum dimethylarginine levels (symmetric) |
ERBB4 |
intron |
24159190
|
| rs10197535 |
chr2 |
213282922 |
0.00000933 |
G |
A |
Serum dimethylarginine levels (symmetric) |
ERBB4 |
intron |
24159190
|
| rs6435701 |
chr2 |
213283512 |
0.00000733 |
A |
G |
Serum dimethylarginine levels (symmetric) |
ERBB4 |
intron |
24159190
|
| rs10201067 |
chr2 |
213284411 |
0.0000085 |
C |
T |
Serum dimethylarginine levels (symmetric) |
ERBB4 |
intron |
24159190
|
| rs13413590 |
chr2 |
213292329 |
0.00000318 |
C |
T |
Serum dimethylarginine levels (symmetric) |
ERBB4 |
intron |
24159190
|
| rs7569142 |
chr2 |
213294557 |
0.00000283 |
C |
T |
Serum dimethylarginine levels (symmetric) |
ERBB4 |
intron |
24159190
|
| rs13393577 |
chr2 |
213296863 |
0.00000000000009 |
T |
C |
Breast cancer |
ERBB4 |
intron |
22452962
|
| rs1505368 |
chr2 |
213297253 |
0.000001 |
G |
A |
Serum dimethylarginine levels (symmetric) |
ERBB4 |
intron |
24159190
|
| rs1505376 |
chr2 |
213303947 |
0.000209 |
T |
C |
Parkinson's disease |
ERBB4 |
intron |
17052657
|
| rs17259208 |
chr2 |
213316586 |
0.00003 |
T |
C |
Kawasaki disease |
ERBB4 |
intron |
22446962
|
| rs6711080 |
chr2 |
213317329 |
0.0009 |
C |
T |
Nicotine smoking |
ERBB4 |
intron |
19268276
|
| rs10168850 |
chr2 |
213334523 |
0.000049 |
C |
T |
Kawasaki disease |
ERBB4 |
intron |
22446962
|